Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
K
014570
vs
K
KOSPI 200
Over the past 12 months, Korean Drug Co Ltd has underperformed KOSPI 200, delivering a return of -29% compared to KOSPI 200's +56% growth.
Stocks Performance
014570 vs KOSPI 200
Performance Gap
014570 vs KOSPI 200
Performance By Year
014570 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Korean Drug Co Ltd
Glance View
Korean Drug Co Ltd is a South Korean pharmaceutical company that develops, makes, and sells medicines for human use. Its business is centered on finished drugs rather than hospitals or medical devices, so it earns money mainly by producing prescription and over-the-counter products and selling them through healthcare and pharmacy channels. The company’s products are used to treat common medical conditions, which means its main customers are doctors, clinics, hospitals, pharmacies, and drug distributors that buy and recommend its medicines. Like many drug makers, it depends on repeat purchases of established products, and its revenue comes from selling its own branded or generic formulations to the local healthcare market. What makes its business model different is its place in the pharmaceutical supply chain: it turns chemical and formulation know-how into regulated medicines that can be prescribed or dispensed to patients. That gives it a role as a manufacturer and marketer of essential healthcare products, where trust, regulatory approval, and consistent product quality matter more than flashy branding.